Rapport Therapeutics, Inc.
RAPP
$27.62
-$0.22-0.79%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -111.48M | -97.70M | -88.31M | -79.70M | -78.31M |
| Total Depreciation and Amortization | 1.02M | 1.01M | 975.00K | 931.00K | 839.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.49M | 18.23M | 14.11M | 11.01M | 15.06M |
| Change in Net Operating Assets | 3.50M | 1.24M | -2.94M | 308.00K | -2.42M |
| Cash from Operations | -87.47M | -77.22M | -76.17M | -67.45M | -64.83M |
| Capital Expenditure | -616.00K | -673.00K | -679.00K | -1.62M | -2.41M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -186.86M | 19.45M | 23.20M | -105.56M | -167.74M |
| Cash from Investing | -187.47M | 18.78M | 22.52M | -107.18M | -170.14M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 270.79M | 270.48M | 13.00K | 159.11M | 159.11M |
| Repurchase of Common Stock | -1.00K | -1.00K | -1.40M | -1.40M | -1.39M |
| Issuance of Preferred Stock | -- | 0.00 | 0.00 | 0.00 | 63.94M |
| Repurchase of Preferred Stock | -- | -- | -- | -29.00K | -29.00K |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -63.00K | 283.00K | 0.00 |
| Cash from Financing | 270.79M | 270.48M | -1.45M | 157.97M | 221.63M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.16M | 212.05M | -55.10M | -16.66M | -13.34M |